These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8047825)

  • 41. The effects of a weakly acidic meal on gastric buffering and postprandial gastro-oesophageal reflux.
    Ravi K; Francis DL; See JA; Geno DM; Katzka DA
    Aliment Pharmacol Ther; 2011 Sep; 34(5):568-75. PubMed ID: 21726258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease.
    Marshall RE; Anggiansah A; Owen WA; Owen WJ
    Eur J Gastroenterol Hepatol; 1998 May; 10(5):385-92. PubMed ID: 9619384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.
    Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
    Lundell L
    Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease.
    Gardner JD; Sloan S; Miner PB; Robinson M
    Aliment Pharmacol Ther; 2003 Apr; 17(7):945-53. PubMed ID: 12656697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eradication of Helicobacter pylori does not increase acid reflux in patients with mild to moderate reflux oesophagitis.
    Tefera S; Hatlebakk JG; Berstad AE; Berstad A
    Scand J Gastroenterol; 2002 Aug; 37(8):877-83. PubMed ID: 12229960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
    Katz PO; Anderson C; Khoury R; Castell DO
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
    Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor.
    Gardner JD; Sloan S; Miner PB; Robinson M
    Aliment Pharmacol Ther; 2003 Apr; 17(7):955-64. PubMed ID: 12656698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
    Roman S; Serraj I; Damon H; Mion F
    Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiology of gastro-oesophageal reflux disease.
    De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K; Marecek P
    Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of the hiatus hernia in gastro-oesophageal reflux disease.
    Gordon C; Kang JY; Neild PJ; Maxwell JD
    Aliment Pharmacol Ther; 2004 Oct; 20(7):719-32. PubMed ID: 15379832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of bile in the oesophagus is associated with less effective oesophageal motility.
    Freedman J; Lindqvist M; Hellström PM; Granström L; Näslund E
    Digestion; 2002; 66(1):42-8. PubMed ID: 12379814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
    Havelund T; Aalykke C; Rasmussen L
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):509-14. PubMed ID: 9187886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impairment of rat oesophageal muscle contractility associated with experimental non-erosive oesophageal mucosal damage.
    Gadelha KKL; Batista-Lima FJ; de Oliveira DMN; Carvalho EF; Sifrim D; Santos AAD; Magalhães PJC
    Exp Physiol; 2019 Feb; 104(2):199-208. PubMed ID: 30561099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 'Bile' in the oesophagus.
    Bremner CG; Mason RJ
    Br J Surg; 1993 Nov; 80(11):1374-6. PubMed ID: 8252339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease.
    Cicala M; Emerenziani S; Caviglia R; Guarino MP; Vavassori P; Ribolsi M; Carotti S; Petitti T; Pallone F
    Aliment Pharmacol Ther; 2003 Sep; 18(6):605-13. PubMed ID: 12969087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease.
    Robinson M; Maton PN; Rodriguez S; Greenwood B; Humphries TJ
    Aliment Pharmacol Ther; 1997 Oct; 11(5):973-80. PubMed ID: 9354209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.